1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Metagenomics in Healthcare Revenue
• 1.4 Market Analysis by Type
  • 1.4.1 Global Metagenomics in Healthcare Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Sample Extraction Kits
  • 1.4.3 Metagenomics Kits
• 1.5 Market by Application
  • 1.5.1 Global Metagenomics in Healthcare Market Share by Application: 2020 VS 2026
  • 1.5.2 Pharmaceutical Industries
  • 1.5.3 Biotechnology Companies
  • 1.5.4 Pathology Laboratories
  • 1.5.5 Academic and Research Laboratories
  • 1.5.6 Others
• 1.6 Coronavirus Disease 2019 (Covid-19): Metagenomics in Healthcare Industry Impact
  • 1.6.1 How the Covid-19 is Affecting the Metagenomics in Healthcare Industry
    • 1.6.1.1 Metagenomics in Healthcare Business Impact Assessment - Covid-19
    • 1.6.1.2 Supply Chain Challenges
    • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  • 1.6.2 Market Trends and Metagenomics in Healthcare Potential Opportunities in the COVID-19 Landscape
  • 1.6.3 Measures / Proposal against Covid-19
    • 1.6.3.1 Government Measures to Combat Covid-19 Impact
    • 1.6.3.2 Proposal for Metagenomics in Healthcare Players to Combat Covid-19 Impact
• 1.7 Study Objectives
• 1.8 Years Considered

2 Global Growth Trends by Regions

• 2.1 Metagenomics in Healthcare Market Perspective (2015-2026)
• 2.2 Metagenomics in Healthcare Growth Trends by Regions
  • 2.2.1 Metagenomics in Healthcare Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Metagenomics in Healthcare Historic Market Share by Regions (2015-2020)
  • 2.2.3 Metagenomics in Healthcare Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Metagenomics in Healthcare Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Metagenomics in Healthcare Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Metagenomics in Healthcare Players by Market Size
  • 3.1.1 Global Top Metagenomics in Healthcare Players by Revenue (2015-2020)
  • 3.1.2 Global Metagenomics in Healthcare Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Metagenomics in Healthcare Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Metagenomics in Healthcare Market Concentration Ratio
  • 3.2.1 Global Metagenomics in Healthcare Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Metagenomics in Healthcare Revenue in 2019
• 3.3 Metagenomics in Healthcare Key Players Head office and Area Served
• 3.4 Key Players Metagenomics in Healthcare Product Solution and Service
• 3.5 Date of Enter into Metagenomics in Healthcare Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

• 4.1 Global Metagenomics in Healthcare Historic Market Size by Type (2015-2020)
• 4.2 Global Metagenomics in Healthcare Forecasted Market Size by Type (2021-2026)

5 Metagenomics in Healthcare Breakdown Data by Application (2015-2026)

• 5.1 Global Metagenomics in Healthcare Market Size by Application (2015-2020)
• 5.2 Global Metagenomics in Healthcare Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Metagenomics in Healthcare Market Size (2015-2020)
• 6.2 Metagenomics in Healthcare Key Players in North America (2019-2020)
• 6.3 North America Metagenomics in Healthcare Market Size by Type (2015-2020)
• 6.4 North America Metagenomics in Healthcare Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Metagenomics in Healthcare Market Size (2015-2020)
• 7.2 Metagenomics in Healthcare Key Players in Europe (2019-2020)
• 7.3 Europe Metagenomics in Healthcare Market Size by Type (2015-2020)
• 7.4 Europe Metagenomics in Healthcare Market Size by Application (2015-2020)

8 China

• 8.1 China Metagenomics in Healthcare Market Size (2015-2020)
• 8.2 Metagenomics in Healthcare Key Players in China (2019-2020)
• 8.3 China Metagenomics in Healthcare Market Size by Type (2015-2020)
• 8.4 China Metagenomics in Healthcare Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Metagenomics in Healthcare Market Size (2015-2020)
• 9.2 Metagenomics in Healthcare Key Players in Japan (2019-2020)
• 9.3 Japan Metagenomics in Healthcare Market Size by Type (2015-2020)
• 9.4 Japan Metagenomics in Healthcare Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Metagenomics in Healthcare Market Size (2015-2020)
• 10.2 Metagenomics in Healthcare Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Metagenomics in Healthcare Market Size by Type (2015-2020)
• 10.4 Southeast Asia Metagenomics in Healthcare Market Size by Application (2015-2020)

11 India

• 11.1 India Metagenomics in Healthcare Market Size (2015-2020)
• 11.2 Metagenomics in Healthcare Key Players in India (2019-2020)
• 11.3 India Metagenomics in Healthcare Market Size by Type (2015-2020)
• 11.4 India Metagenomics in Healthcare Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Metagenomics in Healthcare Market Size (2015-2020)
• 12.2 Metagenomics in Healthcare Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Metagenomics in Healthcare Market Size by Type (2015-2020)
• 12.4 Central & South America Metagenomics in Healthcare Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Illumina
  • 13.1.1 Illumina Company Details
  • 13.1.2 Illumina Business Overview and Its Total Revenue
  • 13.1.3 Illumina Metagenomics in Healthcare Introduction
  • 13.1.4 Illumina Revenue in Metagenomics in Healthcare Business (2015-2020))
  • 13.1.5 Illumina Recent Development
• 13.2 QIAGEN
  • 13.2.1 QIAGEN Company Details
  • 13.2.2 QIAGEN Business Overview and Its Total Revenue
  • 13.2.3 QIAGEN Metagenomics in Healthcare Introduction
  • 13.2.4 QIAGEN Revenue in Metagenomics in Healthcare Business (2015-2020)
  • 13.2.5 QIAGEN Recent Development
• 13.3 PerkinElmer
  • 13.3.1 PerkinElmer Company Details
  • 13.3.2 PerkinElmer Business Overview and Its Total Revenue
  • 13.3.3 PerkinElmer Metagenomics in Healthcare Introduction
  • 13.3.4 PerkinElmer Revenue in Metagenomics in Healthcare Business (2015-2020)
  • 13.3.5 PerkinElmer Recent Development
• 13.4 Thermo Fisher Scientific
  • 13.4.1 Thermo Fisher Scientific Company Details
  • 13.4.2 Thermo Fisher Scientific Business Overview and Its Total Revenue
  • 13.4.3 Thermo Fisher Scientific Metagenomics in Healthcare Introduction
  • 13.4.4 Thermo Fisher Scientific Revenue in Metagenomics in Healthcare Business (2015-2020)
  • 13.4.5 Thermo Fisher Scientific Recent Development
• 13.5 Oxford Nanopore Technologies
  • 13.5.1 Oxford Nanopore Technologies Company Details
  • 13.5.2 Oxford Nanopore Technologies Business Overview and Its Total Revenue
  • 13.5.3 Oxford Nanopore Technologies Metagenomics in Healthcare Introduction
  • 13.5.4 Oxford Nanopore Technologies Revenue in Metagenomics in Healthcare Business (2015-2020)
  • 13.5.5 Oxford Nanopore Technologies Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer

Metagenomics is the study of genetic material recovered directly from environmental samples.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Metagenomics in Healthcare market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Metagenomics in Healthcare industry.
Based on our recent survey, we have several different scenarios about the Metagenomics in Healthcare YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Metagenomics in Healthcare will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Metagenomics in Healthcare market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Metagenomics in Healthcare market in terms of revenue.
Players, stakeholders, and other participants in the global Metagenomics in Healthcare market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Metagenomics in Healthcare market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Metagenomics in Healthcare market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Metagenomics in Healthcare market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Metagenomics in Healthcare market.
The following players are covered in this report:
Illumina
QIAGEN
PerkinElmer
Thermo Fisher Scientific
Oxford Nanopore Technologies
...
Metagenomics in Healthcare Breakdown Data by Type
Sample Extraction Kits
Metagenomics Kits
Metagenomics in Healthcare Breakdown Data by Application
Pharmaceutical Industries
Biotechnology Companies
Pathology Laboratories
Academic and Research Laboratories
Others